Yahoo
Tokyo - Delayed Quote JPY

Kaken Pharmaceutical Co., Ltd. (4521.T)

3,785.00 -45.00 (-1.17%)
At close: November 2 at 3:30:00 PM GMT+9
View in AlphaSpace Currency in JPY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Revenue
76,871,000
76,871,000
94,035,000
72,044,000
72,984,000
Cost of Revenue
36,879,000
36,879,000
35,502,000
33,505,000
33,428,000
Gross Profit
39,991,000
39,991,000
58,532,000
38,539,000
39,555,000
Operating Expense
40,888,000
40,888,000
37,494,000
29,022,000
31,553,000
Operating Income
-897,000
-897,000
21,038,000
9,517,000
8,002,000
Net Non Operating Interest Income Expense
230,000
230,000
49,000
-9,000
-10,000
Pretax Income
2,313,000
2,313,000
19,435,000
9,796,000
6,817,000
Tax Provision
168,000
168,000
5,490,000
1,770,000
1,377,000
Net Income Common Stockholders
2,144,000
2,144,000
13,945,000
8,025,000
5,440,000
Diluted NI Available to Com Stockholders
2,144,000
2,144,000
13,945,000
8,025,000
5,440,000
Basic EPS
56.57
56.57
365.42
212.67
144.80
Diluted EPS
56.57
56.57
365.42
212.67
144.80
Basic Average Shares
37,911
37,911
38,162
37,737
37,571
Diluted Average Shares
37,911
37,911
38,162
37,737
37,571
Total Operating Income as Reported
-899,000
-899,000
21,034,000
9,513,000
7,998,000
Total Expenses
77,767,000
77,767,000
72,996,000
62,527,000
64,981,000
Net Income from Continuing & Discontinued Operation
2,144,000
2,144,000
13,945,000
8,025,000
5,440,000
Normalized Income
-150,572.50
-150,572.50
15,291,030
8,168,360
6,984,928
Interest Income
275,000
275,000
77,000
8,000
7,000
Interest Expense
45,000
45,000
28,000
17,000
17,000
Net Interest Income
230,000
230,000
49,000
-9,000
-10,000
EBIT
2,358,000
2,358,000
19,463,000
9,813,000
6,834,000
EBITDA
5,683,000
5,683,000
22,017,000
12,566,000
9,402,000
Reconciled Cost of Revenue
36,879,000
36,879,000
35,502,000
33,505,000
33,428,000
Reconciled Depreciation
3,325,000
3,325,000
2,554,000
2,753,000
2,568,000
Net Income from Continuing Operation Net Minority Interest
2,144,000
2,144,000
13,945,000
8,025,000
5,440,000
Total Unusual Items Excluding Goodwill
2,475,000
2,475,000
-1,876,000
-175,000
-1,936,000
Total Unusual Items
2,475,000
2,475,000
-1,876,000
-175,000
-1,936,000
Normalized EBITDA
3,208,000
3,208,000
23,893,000
12,741,000
11,338,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
180,427.50
180,427.50
-529,970
-31,640
-391,072
3/31/2023 - 1/1/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: